10-Q: BCB Bancorp Reports Q3 Loss Amid Higher Loan Loss Provisions

Sentiment:

Quarterly Report 5 November 2025 10:00 AM

BCB Bancorp, Inc. reported a net loss for the nine months ended September 30, 2025, primarily driven by a significant increase in provision for credit losses, particularly related to its cannabis loan portfolio.

Capital raiseOn March 15, 2025, completed a private placement of 52 shares of Series K 6.0% Noncumulative Perpetual Stock, resulting in gross proceeds of $520,000.On December 31, 2024, completed a private placement of 497 shares of Series K Preferred Stock, resulting in gross proceeds of $4,970,000.On September 25, 2024, closed a private placement of 136 shares of Series J Noncumulative Perpetual Stock, resulting in gross proceeds of $1,360,000.On June 21, 2024, closed a private placement of 67 shares of Series J Noncumulative Perpetual Stock, resulting in gross proceeds of $670,000.On March 29, 2024, closed a private placement of 269 shares of Series J Preferred Stock, resulting in gross proceeds of $2,690,000.On December 14, 2023, closed a private placement of 1,527 shares of Series J Preferred Stock, resulting in gross proceeds of $15,270,000.On August 29, 2024, issued $40 million of fixed-to-floating subordinated debentures in a private placement.

Worse than expectedA net loss of $498 thousand was reported for the nine months ended September 30, 2025, compared to net income of $15.4 million in the prior year.Provision for credit losses increased by $22.4 million for the nine months ended September 30, 2025, primarily due to a $13.7 million specific reserve for a cannabis-related loan.Non-accrual loans more than doubled to $93.5 million (3.31% of gross loans) at September 30, 2025, from $44.7 million (1.48% of gross loans) at December 31, 2024.Net charge-offs totaled $26.8 million for the nine months ended September 30, 2025, including a $12.7 million charge-off for a cannabis-related relationship.Other real estate owned (OREO) increased to $20.077 million from zero, indicating asset quality deterioration.

Summary

A net loss of $498 thousand was recorded for the nine months ended September 30, 2025, a significant decline from net income of $15.4 million for the same period in 2024.
Net income for the three months ended September 30, 2025, was $4.3 million, down from $6.7 million in the third quarter of 2024.
Total assets decreased by $246.0 million, or 6.8%, to $3.353 billion at September 30, 2025, from $3.599 billion at December 31, 2024.
Loans receivable, net, decreased by $207.3 million, or 6.9%, to $2.789 billion.
The allowance for credit losses increased by $3.0 million to $37.8 million, representing 1.34% of gross loans, up from 1.15% at December 31, 2024.
Provision for credit losses surged to $29.8 million for the nine months ended September 30, 2025, from $7.4 million in the prior year, largely due to a $13.7 million specific reserve for a cannabis-related loan.
Non-accrual loans increased significantly to $93.5 million, or 3.31% of gross loans, at September 30, 2025, from $44.7 million, or 1.48% of gross loans, at December 31, 2024.
Deposits decreased by $63.5 million, or 2.3%, to $2.687 billion.
Debt obligations decreased by $174.4 million to $323.9 million, primarily due to paydowns of FHLB advances.
Net interest margin improved to 2.88% for the third quarter of 2025 from 2.58% for the third quarter of 2024, and to 2.76% for the nine months ended September 30, 2025, from 2.56% for the same period in 2024.
Stockholders' equity decreased by $5.5 million, or 1.7%, to $318.5 million.

Sentiment

Score: 3

Explanation: The net loss, substantial increase in loan loss provisions, and significant rise in non-accrual loans, particularly related to the cannabis sector, indicate severe asset quality deterioration and a challenging operating environment. While net interest margin improved, the overall financial performance is concerning.

Positives

Net interest margin improved to 2.88% for the three months ended September 30, 2025, compared to 2.58% for the same period in 2024, and to 2.76% for the nine months ended September 30, 2025, compared to 2.56% in the prior year.
Interest expense decreased by $6.3 million for the three months ended September 30, 2025, and by $15.9 million for the nine months ended September 30, 2025, primarily due to lower average rates paid on interest-bearing liabilities and reduced borrowed funds.
Accumulated other comprehensive loss decreased from $(5.239) million at December 31, 2024, to $(2.956) million at September 30, 2025, indicating an improvement in the fair value of available-for-sale securities.
Non-interest income increased by $4.6 million for the nine months ended September 30, 2025, largely due to the absence of a $4.8 million loss on sale of loans recorded in 2024.
The Bank exceeded all regulatory capital requirements, with a Community Bank Leverage Ratio of 10.60% at September 30, 2025, well above the 9% minimum.
Available funding capacity includes $200.3 million from the FHLB and $223.3 million from the Federal Reserve Bank Discount Window, utilizing unencumbered loan collateral.

Negatives

A net loss of $498 thousand was reported for the nine months ended September 30, 2025, a significant decrease from net income of $15.4 million in the prior year.
Net income for the third quarter of 2025 decreased to $4.3 million from $6.7 million in the third quarter of 2024.
Provision for credit losses increased substantially to $29.8 million for the nine months ended September 30, 2025, from $7.4 million in the prior year, primarily due to a $13.7 million specific reserve for a cannabis-related loan that was subsequently charged off.
Non-accrual loans more than doubled to $93.5 million (3.31% of gross loans) at September 30, 2025, from $44.7 million (1.48% of gross loans) at December 31, 2024.
Total assets decreased by $246.0 million (6.8%), driven by decreases in net loans and cash and cash equivalents.
Loans receivable, net, decreased by $207.3 million (6.9%), with significant declines in commercial real estate, multi-family, construction, and commercial business loans.
Deposits decreased by $63.5 million (2.3%), with brokered deposits and transaction accounts declining by $68.5 million and $59.8 million, respectively.
Stockholders' equity decreased by $5.5 million (1.7%), primarily due to the net loss and dividend payments.
Net charge-offs totaled $26.8 million for the nine months ended September 30, 2025, compared to $6.3 million in the prior year, including a $12.7 million charge-off for a cannabis-related relationship.
Other real estate owned (OREO) increased to $20.077 million at September 30, 2025, from zero at December 31, 2024, due to the reclassification of collateral from a charged-off cannabis loan.
Non-interest expense increased by $3.7 million (8.8%) for the nine months ended September 30, 2025, primarily due to higher salaries and employee benefits, data processing, and professional fees.
The cannabis loan portfolio, largely secured by real estate, poses an increased amount of credit risk, and the industry faces operating challenges, potentially requiring material reserves in future periods.

Risks

Unfavorable economic conditions in the United States generally and particularly in primary market areas (New Jersey and New York).
Impact of global economic trends and geopolitical risks, including ongoing conflicts in Ukraine and the Middle East, and changes in the rate of investment or economic growth.
Supply chain disruptions and labor shortages.
Impact of any future pandemics or other natural disasters.
Ability to effectively attract and deploy deposits.
Changes in corporate strategies, the composition of assets, or funding methods.
Shifts in investor sentiment or behavior in the securities, capital, or other financial markets, including changes in market liquidity or volatility.
Effects of declines in real estate values that may adversely impact the collateral underlying loans.
Increase in unemployment levels and slowdowns in economic growth.
Impact of changes in interest rates and the credit quality and strength of underlying collateral on loan and investment securities portfolios.
Credit risk associated with the loan portfolio, particularly cannabis-related loans due to federal illegality and operating challenges, which could subject borrowers to criminal prosecution and other sanctions.
Changes in the quality and composition of the Bank's loan and investment portfolios.
Changes in ability to access cost-effective funding.
Legislative and regulatory changes, including increases in Federal Deposit Insurance Corporation (FDIC) insurance rates.
Monetary and fiscal policies of the federal and state governments, including changes in government priorities or budgets.
Changes in tax policies, rates, and regulations of federal, state, and local tax authorities.
Demands for loan products and financial services.
Competition in the financial services market.
Changes in the securities or secondary mortgage markets.
Ability to successfully integrate acquired businesses.
Changes in consumer spending.
Ability to retain key employees.
Effects of any reputational, credit, interest rate, market, operational, legal, liquidity, or regulatory risk.
Potential impact of regulatory requirements, matters, litigation, or other legal actions which could adversely affect operating results.
Civil unrest in the communities served.

Future Outlook

Management believes that the credit quality headwinds are temporary and the long-term earnings power of the Company maintains a positive outlook. The Company will continue evaluating economic conditions at future reporting periods for goodwill impairment triggering events and expects to have sufficient funds available to meet current loan commitments in the normal course of business.

Management Comments

"Management believes that the credit quality headwinds are temporary and the long-term earnings power of the Company maintains a positive outlook."
"Management believes that the allowance for credit losses on loans was adequate at September 30, 2025 and December 31, 2024."
"The Company was well-positioned with adequate levels of cash and liquid assets as of September 30, 2025 and a significant amount of available borrowing capacity with FHLB and Federal Reserve Bank Discount Window."

Industry Context

The filing highlights challenges in the cannabis industry, noting that while medical and recreational use are legal in New Jersey and New York, federal illegality poses risks to borrowers. This indicates a specific industry segment facing regulatory and operational headwinds, impacting the bank's loan portfolio. The significant increase in non-accrual loans and provision for credit losses, particularly in commercial and business express segments, suggests broader economic pressures or specific portfolio weaknesses that could be indicative of a tightening credit environment or increased default risk in certain sectors. The improvement in net interest margin, despite a decrease in total interest income, reflects the bank's ability to manage interest expense, possibly by reducing reliance on higher-cost wholesale funding (FHLB advances, brokered deposits), which is a common strategy for banks in a rising or volatile interest rate environment.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Accounting Policy/Disclosure Update	The Company is evaluating the impact of adopting ASU 2023-09, Income Taxes (Topic 740)Improvements to Income Tax Disclosures, which is effective for annual periods beginning after December 15, 2024. This ASU aims to enhance the transparency of income tax disclosures.	After December 15, 2024	Expected to enhance transparency of income tax disclosures, requiring tabular reconciliation using percentages and reporting currency amounts, and qualitative descriptions of state and local tax effects.

Legal Proceedings

The Company is involved, from time to time, as plaintiff or defendant in various legal actions arising in the normal course of business. As of September 30, 2025, no material legal proceedings were ongoing that would have a material adverse effect on financial condition or results of operations if determined adversely.

Stakeholder Impact

Shareholders face a negative impact due to the net loss, decrease in stockholders' equity, and significant increase in non-accrual loans and charge-offs, despite a declared common stock dividend.
Employees may benefit from continued equity incentive plans and an increase in salaries and employee benefits, indicating ongoing investment in personnel.
Customers may experience potential impacts on lending availability or terms due to increased credit risk in certain loan segments, while overall deposits decreased.
Creditors (depositors, FHLB, subordinated debenture holders) benefit from the Bank remaining well-capitalized and reduced reliance on higher-cost wholesale funding, although the overall financial performance shows stress.

Next Steps

Management will continue evaluating economic conditions at future reporting periods for goodwill impairment triggering events.
A cash dividend of $0.16 per share was declared on October 27, 2025, payable on November 24, 2025, to shareholders of record on November 10, 2025.
The Company is currently evaluating the impact of ASU 2023-09, Income Taxes (Topic 740)Improvements to Income Tax Disclosures, which is effective for annual periods beginning after December 15, 2024.

Key Dates

Date	Description
2023-01-01	Beginning balance for the effect of adopting ASU No. 2016-13 ('CECL').
2023-01-31	Awards of 27,000 shares of restricted stock declared for members of the Board of Directors, vesting over a 4-year period.
2023-06-30	Award of 25,252 shares of restricted stock declared for a director and executive officer, fully vesting on the anniversary of the award date.
2023-09-14	Redemption of 22 outstanding shares of Series H 3.5% Noncumulative Perpetual Preferred Stock for $220,000.
2023-12-14	Closed a private placement of 1,527 shares of Series J Noncumulative Perpetual Stock, resulting in gross proceeds of $15,270,000.
2023-12-31	Redeemed the remaining 1,101 outstanding shares of Series H 3.5% Noncumulative Perpetual Preferred Stock for $11.0 million during the fourth quarter.
2024-03-29	Closed a private placement of 269 shares of Series J Noncumulative Perpetual Stock, resulting in gross proceeds of $2,690,000.
2024-04-25	Awards of 30,000 and 20,000 shares of restricted stock declared for an executive officer, vesting over 2 and 3 years, respectively.
2024-06-21	Closed a private placement of 67 shares of Series J Noncumulative Perpetual Stock, resulting in gross proceeds of $670,000.
2024-08-29	Issued $40 million of fixed-to-floating subordinated debentures in a private placement.
2024-09-25	Closed a private placement of 136 shares of Series J Noncumulative Perpetual Stock, resulting in gross proceeds of $1,360,000.
2024-10-31	Conducted a qualitative assessment of goodwill and determined it was not impaired.
2024-12-15	ASU 2023-09, Income Taxes (Topic 740)Improvements to Income Tax Disclosures, is effective for annual periods beginning after this date.
2024-12-31	Completed a private placement of 497 shares of Series K 6.0% Noncumulative Perpetual Stock, resulting in gross proceeds of $4,970,000.
2025-02-03	Awards of 43,773 shares of restricted stock declared for members of the Board of Directors, vesting over a 1-year period.
2025-02-24	Grants of 63,763 options declared for certain officers, vesting over a 3-year period.
2025-03-15	Completed a private placement of 52 shares of Series K 6.0% Noncumulative Perpetual Stock, resulting in gross proceeds of $520,000.
2025-05-31	Performed an interim goodwill impairment assessment due to a triggering event (net loss in Q1 2025 and sustained decline in stock price), determining no impairment was needed.
2025-09-30	End of the quarterly reporting period.
2025-10-27	Board of Directors declared a cash dividend of $0.16 per share to shareholders of record on November 10, 2025.
2025-11-01	BCB Bancorp, Inc. had 17,228,206 shares of common stock outstanding.
2025-11-05	Date of filing of the Form 10-Q.
2025-11-10	Record date for the declared cash dividend of $0.16 per share.
2025-11-24	Payment date for the declared cash dividend of $0.16 per share.

Recommendation

sell

The company reported a net loss for the nine-month period, a significant increase in non-accrual loans, and substantial loan loss provisions, particularly from its cannabis loan portfolio. This indicates severe asset quality deterioration and heightened credit risk. While the net interest margin improved and the bank remains well-capitalized, the significant increase in problem assets and the resulting net loss are strong indicators of underlying operational and credit challenges that are likely to negatively impact future profitability and shareholder value. The reclassification of a large cannabis loan to Other Real Estate Owned further underscores these concerns. Investors should consider selling to mitigate exposure to these deteriorating fundamentals.

Keywords

BCB Bancorp, BCBP, Community Bank, Financial Results, Quarterly Report, SEC Filing, Loan Loss Provision, Credit Quality, Non-accrual Loans, Cannabis Loans, Net Interest Margin, Deposits, FHLB Advances, Stockholders Equity, Banking, New Jersey, New York

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.